InterAct Therapeutics, Inc.

New Filing
CIK: 0002107143·Other Health Care·DELAWARE·Filed: Jul 21, 2026
Total Offering

$2,000,000

Amount Sold

$250,000

Investors

1

First Sale

Jul 20, 2026

Offering Details

Type
Debt
Exemptions
Rule 506(b)
Entity Type
Corporation
Year Incorporated
2025
Non-Accredited Investors
No

Related Persons

NameRole
Daniel Hargrove
Isaac Chan

Company

InterAct Therapeutics, Inc.

3060 PEGASUS PARK DRIVE

DALLAS, TX, 75247

2107102867

SEC Filing

0002107143-26-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
InterAct Therapeutics, Inc. Form D Filing — $2,000,000 | FilingFlow